Evidence not advocacy
Rather than advocating for a particular treatment approach, this session provides clinicians with a structured review of the available data, helping them understand what is known, what remains uncertain, and where important limitations exist within the current evidence base.
Who Is This Session For?
This session is designed for healthcare professionals seeking a clearer understanding of the evidence surrounding cannabis and cannabinoid medicines in the context of brain cancer and its treatment.
Relevance for Clinicians
It is particularly relevant to clinicians who encounter patients already using, considering, or asking about cannabinoid therapies and who want to approach these conversations with an informed understanding of the available clinical evidence.
About this course
Learning Outcomes At the end of this module, learners should be able to: 1. Describe current treatment of glioblastoma multiforme (GBM). 2. Describe the new typology or classification of high grade gliomas in adults. 3. Explain some key anti-cancer actions of cannabinoids in brain cancer. 4. Critique the level of human evidence for the use of medicinal cannabis in treatment of GBM. 5. Provide a rationale for the use of medicinal cannabis in patients with GBM.
A/Prof Janet Schloss
A/Prof Janet Schloss has a background as a naturopath and clinical nutritionist and completed her Phd at School of Medicine, University of Queensland. Janet has worked extensively conducting clinical trials and had led one of the world’s first trials on cannabis and brain cancer and the largest cannabis and sleep trial in Australia. In addition, Janet has a private practice seeing patients for over 25 years predominantly for oncology. A/Prof Schloss has focused on oncology for over 20 years and works closely with medical oncologists, radiation oncologists and surgeons. She has extensive knowledge on trial design, trial implementation, quantitative and qualitative research, in conjunction with extensive industry knowledge. She regularly presents at conferences in Australia and worldwide and to date has over 80 peer reviewed published journal articles.
Curriculum
-
-
(Included in full purchase)
Welcome to your learning platform
-
(Included in full purchase)
Welcome Prof Janet Schloss
-
(Included in full purchase)
Learning Outcomes
-
(Included in full purchase)
-
-
(Included in full purchase)
Your Video Settings
-
(Included in full purchase)
Cannabis & Brain Cancer Part 1
-
(Included in full purchase)
Cannabis & Brain Cancer Part 2
-
(Included in full purchase)
-
-
(Included in full purchase)
End of Module Quiz
-
(Included in full purchase)
Certificate of Completion
-
(Included in full purchase)
Critically evaluate the evidence surrounding cannabis and cannabinoid medicines.
Know the evidence today.
$100.00